PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1558351
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1558351
According to Stratistics MRC, the Global Subperiosteal Dental Implants Market is accounted for $1.19 billion in 2024 and is expected to reach $1.96 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Subperiosteal dental implants are a specialized type of implant used primarily in patients who lack sufficient jawbone density for traditional endosteal implants. Unlike endosteal implants, which are placed directly into the jawbone, subperiosteal implants are positioned beneath the periosteum, the connective tissue covering the bone. This approach involves placing a metal framework or mesh directly on the jawbone, but beneath the gum tissue. Over time, the gum tissue grows over the framework, allowing for attachment of artificial teeth or crowns. Subperiosteal implants are generally used when bone grafting or other augmentation procedures are not feasible or desirable. They offer a viable solution for patients with severe bone loss or anatomical limitations that prevent the use of conventional implants.
According to data updated by WHO in March 2023, it is estimated that severe periodontal diseases impact approximately 19% of adults globally, totaling over 1 million cases globally.
Growing popularity of cosmetic dentistry
The rising popularity of cosmetic dentistry has significantly advanced the field of subperiosteal dental implants, revolutionizing both function and aesthetics. Subperiosteal implants, which are placed beneath the gum but above the jawbone, have seen enhancements driven by the increasing demand for high-quality, visually appealing dental solutions. Innovations in materials and techniques, such as 3D imaging and custom implant design, have improved the precision and success rates of these implants. The cosmetic dentistry focus on achieving natural-looking results has led to more refined implant designs that blend seamlessly with the patient's existing dental structure.
Surgical complexity
Subperiosteal dental implants, while a viable solution for patients with insufficient bone density, face significant challenges due to their surgical complexity. These implants are placed beneath the periosteum but above the bone, requiring intricate planning and precise execution. The procedure involves creating a custom metal framework that fits the patient's jawbone contour, which necessitates detailed imaging and often advanced computer-aided design techniques. The complexity arises from the need for meticulous surgical preparation to ensure the framework is correctly positioned and securely integrated.
Expansion of dental implant services
The expansion of dental implant services is significantly advancing the field of subperiosteal dental implants, which are used for patients who lack sufficient bone height or density for traditional implants. This approach involves placing a metal framework on top of the jawbone but under the gum tissue, offering a more suitable option for those with inadequate bone structure. Recent innovations in imaging technology, such as 3D scanning and advanced computer-guided planning, have enhanced the precision and customization of these implants, improving their fit and longevity. Additionally, the development of stronger and more biocompatible materials, along with refined surgical techniques, has increased the success rate and comfort of subperiosteal implants.
Regulatory and approval issues
Regulatory and approval issues are significantly hindering the advancement of subperiosteal dental implants, which are a specialized form of dental implant used when traditional implants are not feasible. One major challenge is the rigorous regulatory requirements imposed by agencies such as the FDA. These requirements often include extensive clinical trials, which can be costly and time-consuming. The unique nature of subperiosteal implants, which involve a custom-fit metal framework placed on top of the jawbone, adds complexity to the approval process. Each implant needs to be individually assessed for safety and effectiveness, complicating mass production and widespread use. The lack of standardized protocols and long-term data on their outcomes further delays approval.
The COVID-19 pandemic significantly impacted the field of subperiosteal dental implants, primarily due to disruptions in dental care and changes in patient priorities. The pandemic led to the postponement of non-emergency dental procedures, including the placement of subperiosteal implants, which are complex and often require multiple appointments and extended treatment times. Heightened health and safety concerns prompted increased use of personal protective equipment and infection control measures, complicating the implementation of such procedures. Financially, many patients faced economic hardships, leading to deferrals or cancellations of elective treatments like dental implants. The pandemic also accelerated the adoption of virtual consultations and digital technologies, which, while beneficial in many aspects, did not fully address the challenges specific to subperiosteal implants.
The Zirconium segment is expected to be the largest during the forecast period
Zirconium segment is expected to be the largest during the forecast period. Zirconium is revolutionizing the field of subperiosteal dental implants with its superior biocompatibility, strength, and aesthetic qualities. Unlike traditional materials, zirconium, a type of ceramic, integrates seamlessly with the bone and surrounding tissues, minimizing the risk of rejection and inflammation. Its high durability and resistance to corrosion ensure a long-lasting implant, while its tooth-colored appearance provides a more natural look compared to metallic alternatives. The use of zirconium in subperiosteal implants, which are placed under the periosteum (the membrane covering the bone) rather than directly in the bone, offers a less invasive option for patients with insufficient bone density or those seeking a less noticeable implant.
The Dental Service Organizations segment is expected to have the highest CAGR during the forecast period
Dental Service Organizations segment is expected to have the highest CAGR during the forecast period. Dental Service Organizations (DSOs) are enhancing subperiosteal dental implants to improve patient outcomes and streamline procedures. Subperiosteal implants are a type of dental implant used when there's insufficient bone structure for traditional implants. Recent advancements focus on refining the customization and material quality of these implants, using 3D imaging and printing technology to create precise, patient-specific implants that ensure better fit and stability. This enhancement not only increases the success rate of the implants but also reduces recovery time and postoperative discomfort. By integrating these innovations, DSOs aim to offer more effective solutions for patients with complex dental needs, thus expanding their treatment options and improving overall satisfaction.
Asia Pacific region commanded the largest share of the market over the projected period. By fostering alliances between local dental practitioners, international implant manufacturers, and research institutions, the region is witnessing enhanced innovation and improved clinical outcomes. These partnerships facilitate the exchange of cutting-edge technologies, research findings, and best practices, leading to more effective and tailored implant solutions for diverse patient needs. Moreover, shared resources and expertise contribute to the development of cost-effective solutions and training programs, thereby elevating the standard of dental care. Overall, this synergy between various stakeholders is accelerating advancements in subperiosteal implants and improving patient outcomes across the Asia-Pacific region
Government regulations ensure that implants meet high clinical and ethical standards, fostering trust among patients and practitioners, Europe region is poised to hold substantial growth during the extrapolated period. By implementing stringent guidelines for materials, design and manufacturing processes, European authorities help ensure that only the most reliable and effective products reach the market. Additionally, regulatory frameworks support innovation by setting clear pathways for new technologies and techniques to be approved and integrated into clinical practice across the region. This regulatory oversight not only protects patient health but also stimulates industry growth by encouraging research and development within a well-defined legal structure throughout the region.
Key players in the market
Some of the key players in Subperiosteal Dental Implants market include Cortex Dental Implants Ltd, AB Dental Devices Ltd, Danaher Corporation, Dentium Co., Ltd, Dutton Dental Concepts, Inc, Heraeus Kulzer GmbH, Megagen Implant Co., Ltd, MIS Implants Technologies Ltd, Straumann Holding AG, Technovent Ltd and Zimmer Biomet Holdings, Inc.
In March 2024, BoneEasy launched tailored implant including tailed subperiosteal implants. The implant uses 3D software to develop a model for personalized implant manufacturing.
In May 2022, AB Dental Devices Ltd collaborated with Trucare Group to launch its dental business in the UAE. AB dental offers implants systems including subperiosteal dental implants.
In April 2022, BoneEasy launched Implantize Compact, a new concept of subperiosteal implant with perforations in the implant plate to allow passage of fibers for the soft tissue integration.